ಗರ್ಭಾವಸ್ಥೆಯ ಲ್ಯಾಬ್ ಪರೀಕ್ಷೆಗಳು
HIV Test in Pregnancy (PPTCT Program)
Prevents mother-to-child transmission — treatment during pregnancy reduces risk to less than 2%
ಇದು ಏನನ್ನು ಅಳೆಯುತ್ತದೆ?
The HIV test screens for infection with the Human Immunodeficiency Virus (HIV), which causes AIDS. In pregnancy, the priority concern is Prevention of Parent-to-Child Transmission (PPTCT) — the national programme under which all pregnant women in India are offered HIV testing. The test detects HIV antibodies or the p24 antigen in blood (4th-generation combination test). HIV can be transmitted to the baby during pregnancy (across the placenta), during labour and delivery (exposure to infected blood), and through breastfeeding.
ಇದನ್ನು ಯಾವಾಗ ಸೂಚಿಸಲಾಗುತ್ತದೆ?
At the first antenatal (booking) visit as part of the mandatory PPTCT programme. Testing is voluntary (informed consent required) and confidential. A repeat test may be offered late in pregnancy in high-prevalence areas or if there is new risk exposure.
ಗರ್ಭಾವಸ್ಥೆಯಲ್ಲಿ ಸಾಮಾನ್ಯ ವ್ಯಾಪ್ತಿಗಳು
ಅಸಹಜ ಫಲಿತಾಂಶದ ಅರ್ಥವೇನು?
If the HIV test is reactive (positive), a confirmatory Western blot or more sensitive test is performed. An HIV-positive pregnant woman without treatment has a 20–45% risk of transmitting the virus to her baby (15–20% during pregnancy and delivery, 15–25% through breastfeeding over 24 months). With antiretroviral therapy (ART) started promptly in pregnancy, viral load can be suppressed to undetectable levels — reducing vertical transmission risk to less than 2%. This is the transformative achievement of the PPTCT programme. ART is safe in pregnancy, does not cause birth defects, and protects both mother and baby. The goal is for every HIV-exposed baby to be born HIV-negative.
ದಕ್ಷಿಣ ಭಾರತದ ಮಹಿಳೆಯರಿಗೆ ಇದರ ಅರ್ಥವೇನು
Karnataka, Andhra Pradesh, Tamil Nadu, and Maharashtra have historically had higher HIV prevalence than other Indian states, though rates have declined significantly with the PPTCT programme. ICTC (Integrated Counselling and Testing Centres) and ARTC (ART Centres) are present at district hospitals and larger primary health centres across South India — providing free testing, counselling, and free ART. Counselling is confidential; healthcare workers are bound by strict confidentiality rules. In Tamil Nadu and Karnataka, the PPTCT programme is well-integrated into antenatal care and has achieved major reductions in paediatric HIV.
ಪದೇ ಪದೇ ಕೇಳಲಾಗುವ ಪ್ರಶ್ನೆಗಳು
Is HIV testing mandatory in pregnancy?
In India, HIV testing in pregnancy is offered to all women under the PPTCT programme and is strongly recommended — but it is voluntary, not compulsory. You must provide informed consent. Testing is confidential and the result cannot be shared without your permission. Refusing the test will not affect your access to other antenatal care.
If I test positive, will my family be told?
No. HIV test results are strictly confidential under national guidelines and the law. Healthcare providers cannot disclose your result to family members, your employer, or anyone else without your explicit consent. You will be counselled on whether and how to inform your partner.
Is ART safe to take during pregnancy?
Yes. The first-line ART regimen used in India for HIV-positive pregnant women (typically TDF + 3TC + DTG or earlier regimens) is well-studied and proven safe in pregnancy. Starting ART reduces your viral load, protects your own health, and dramatically reduces the chance of your baby being born with HIV. Benefits vastly outweigh any theoretical risks. Do not stop ART without medical advice.
Can I breastfeed if I am HIV positive?
This is complex. WHO guidelines for low-resource settings recommend breastfeeding while on ART — because diarrhoea and malnutrition from unsafe water and formula feeding may pose greater risks than the small residual HIV transmission risk when viral load is suppressed. Indian NACO guidelines currently recommend that HIV-positive mothers on effective ART may breastfeed exclusively for 6 months. Your doctor and ICTC counsellor will guide you based on your specific viral load, ART adherence, and local context.
What testing does my baby need after birth?
Babies born to HIV-positive mothers need: nevirapine syrup (prophylaxis) for 6 weeks after birth; HIV Early Infant Diagnosis (EID) using PCR test at 6 weeks of age (HIV antibody tests are not useful before 18 months because maternal antibodies are present); repeat PCR at 6 months and 12 months; HIV antibody test at 18 months. This schedule is managed through the ARTC. With full implementation of PPTCT, virtually all HIV-exposed babies can be confirmed HIV-negative.